Specifications - PDL Bioharma Biotech Manufacturing Facility, Brooklyn Park, Minnesota, USA

Key Data
Order year	2002
Project type	New biologics manufacturing facility (Phase 1)
Location	Brooklyn Park, Minnesota, USA
Estimated investment	$200m
Completion	Structural 2004, validation 2006–2007
Output chemicals	Humanised monoclonal antibodies
Key Players
Sponsor	Protein Design Laboratories Inc
Designer	Fluor Corporation, Dell Comm
Contractors	Fluor Corporation, Dell Comm, Ortronics, Berk-Tek
Financing	Protein Design Laboratories Inc
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems
Senn Chemicals - Amino Acid Derivatives, Un-Natural Amino Acids, Peptides, Resins, Carbohydrates And Reagents For The Pharmaceutical, Nutraceutical + Cosmetic Industry